Detalles del proyecto
Description
DESCRIPTION (provided by applicant): WARCEF-STAT and WARCEF-CLIN are two highly coordinated units which together constitute WARCEF, a two-arm (1:1) double-blind randomized multicenter clinical trial. Its primary aim is to test the primary null hypothesis of no difference between warfarin (INR 2.5-3, target 2.75) and aspirin (325 mg/day) therapies in time to the first to occur of death from any cause, ischemic stroke, or symptomatic non-fatal intracerebral hemorrhage (ICH) among patients with low (
| Estado | Finalizado |
|---|---|
| Fecha de inicio/Fecha fin | 9/30/01 → 8/31/13 |
Financiación
- National Institute of Neurological Disorders and Stroke: $5,534,164.00
- National Institute of Neurological Disorders and Stroke: $2,081,306.00
- National Institute of Neurological Disorders and Stroke: $1,000,000.00
- National Institute of Neurological Disorders and Stroke: $2,043,118.00
- National Institute of Neurological Disorders and Stroke: $1,684,927.00
- National Institute of Neurological Disorders and Stroke: $2,168,405.00
- National Institute of Neurological Disorders and Stroke: $200,000.00
- National Institute of Neurological Disorders and Stroke: $2,607,698.00
- National Institute of Neurological Disorders and Stroke: $1,995,081.00
- National Institute of Neurological Disorders and Stroke: $1,982,994.00
Keywords
- Cardiología y medicina cardiovascular
Huella digital
Explore los temas de investigación que se abordan en este proyecto. Estas etiquetas se generan con base en las adjudicaciones/concesiones subyacentes. Juntos, forma una huella digital única.